Patents by Inventor Helen Susanne Price

Helen Susanne Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8933132
    Abstract: The invention relates to novel piperazine compounds of formula (I): to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial, i.e. in particular to treat pain.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: January 13, 2015
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: David Norton, Daniele Andreotti, Simon E. Ward, Roberto Profeta, Simone Spada, Helen Susanne Price
  • Publication number: 20140038976
    Abstract: The invention relates to novel piperazine compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial, i.e. in particular to treat pain.
    Type: Application
    Filed: January 19, 2012
    Publication date: February 6, 2014
    Inventors: David Norton, Daniele Andreotti, Simon E. Ward, Roberto Profeta, Simone Spada, Helen Susanne Price
  • Patent number: 8207213
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Grant
    Filed: February 1, 2007
    Date of Patent: June 26, 2012
    Assignee: Glaxo Group Limited
    Inventors: Mark Patrick Healy, Gerard Martin Paul Giblin, Helen Susanne Price
  • Patent number: 8026270
    Abstract: The present invention relates to naphthalene derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: September 27, 2011
    Assignee: Glaxo Group Limited
    Inventors: Gerard Martin Paul Giblin, Mark Patrick Healy, Helen Susanne Price
  • Publication number: 20110092561
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Application
    Filed: February 1, 2007
    Publication date: April 21, 2011
    Inventors: Mark Patrick Healy, Gerard Martin Paul Giblin, Helen Susanne Price
  • Publication number: 20100273853
    Abstract: A compound of formula (1) or a pharmaceutically acceptable derivative thereof, where R1, R2, R3, R4, R5, X and Y are as defined in the specification; corresponding processes for preparing; pharmaceutical compositions comprising; and medicinal uses of such compounds.
    Type: Application
    Filed: August 16, 2007
    Publication date: October 28, 2010
    Inventors: Gerard Martin Paul Giblin, Mark Patrick Healy, David George Livermore, Helen Susanne Price, Martin Edward Swarbrick
  • Publication number: 20100069457
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1R2R3, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Application
    Filed: July 26, 2007
    Publication date: March 18, 2010
    Inventors: Gerard Martin Paul Giblin, Mark Patrick Healy, Helen Susanne Price
  • Publication number: 20090318523
    Abstract: The present invention relates to benzoisoindole phenylacetic acid derivatives, corresponding pharmaceutical compositions, preparation processes and uses in medicine as EP4 receptor angonists.
    Type: Application
    Filed: November 19, 2007
    Publication date: December 24, 2009
    Inventors: Gerald Martin Paul Giblin, Mark Patrick Healy, Helen Susanne Price
  • Publication number: 20090312388
    Abstract: The present invention relates to naphthalene derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.
    Type: Application
    Filed: July 26, 2007
    Publication date: December 17, 2009
    Inventors: Gerard Martin Paul Giblin, Mark Patrick Healy, Helen Susanne Price
  • Publication number: 20090239845
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein Z, R1, R2a, R2b, R10, R11 and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: April 24, 2006
    Publication date: September 24, 2009
    Inventors: Elizabeth Ann Conway, Gerard Martin Paul Giblin, Mairi Gibson, Adrian Hall, Thomas George Christopher Hayhow, Mark Patrick Healy, David Nigel Hurst, Ian Reginald Kilford, Stephen Carl McKeown, Alan Naylor, Helen Susanne Price, Derek Anthony Rawlings